Last reviewed · How we verify
NCT05713903
Laparoscopic Versus Open Right Colectomy for Right Colon Cancer
NA trial testing Laparoscopic right colectomy in Colon Cancer in 114 participants. Currently enrolling.
10 January 2027
Quick facts
| Lead sponsor | Larissa University Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 114 |
| Start date | 6 February 2023 |
| Primary completion | 10 January 2027 |
| Estimated completion | 10 January 2028 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- Laparoscopic right colectomy
- Open right colectomy
Conditions studied
- Colon Cancer — all drugs for Colon Cancer →
Sponsor
Larissa University Hospital
Who can join
Adults 18 to 90, any sex, with Colon Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research protocol is to compare open versus laparoscopic right colectomy (according to the CME technique of complete mesocolic excision) for right colon cancer. This study will be designed as a prospective randomized controlled trial. The comparison of the two techniques will include endpoints regarding the quality characteristics of the specimens and the oncological results. In addition, the effectiveness of the two methods will be evaluated in terms of the early and late postoperative period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05713903
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Laparoscopic right colectomy
Trials testing the same drug.
- NCT03422588 — Surgical Stress and Intracorporeal Anastomosis · NA · completed
Other recruiting trials for Colon Cancer
Currently open trials in the same condition.
- NCT06923787 — Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patient · Phase 2 · recruiting
- NCT07279077 — Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advance · Phase 2 · recruiting
- NCT07205965 — The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors · NA · active not recruiting
- NCT07285356 — Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy · NA · recruiting
- NCT07161713 — SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors · NA · recruiting
Other Larissa University Hospital trials
Trials by the same sponsor.
- NCT07402005 — The Correlation of Lewis Antigens With VTE · not yet recruiting
- NCT07162324 — A Multicenter, Prospective Study for Glioblastoma Patients · not yet recruiting
- NCT07412301 — The Effect of Celiac Axis Stenosis on Morbidity After Pancreatoduodenectomy - A Prospective Study · active not recruiting
- NCT07066566 — The Effect of Asymmetrical vs. Symmetrical High Flow Nasal Cannula on the Work of Breathing · NA · recruiting
- NCT05829083 — DUET Versus Standard Interface for Hypercapnic COPD Patients · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05713903 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Larissa University Hospital
- Last refreshed: 4 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05713903.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing